Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthy Extracts (HYEX) Debt to Equity (2016 - 2022)

Healthy Extracts filings provide 7 years of Debt to Equity readings, the most recent being $0.05 for Q3 2022.

  • On a quarterly basis, Debt to Equity fell 70.04% to $0.05 in Q3 2022 year-over-year; TTM through Sep 2022 was $0.05, a 70.04% decrease, with the full-year FY2021 number at $0.07, up 15.51% from a year prior.
  • Debt to Equity hit $0.05 in Q3 2022 for Healthy Extracts, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $4.31 in Q1 2019 to a low of -$30.48 in Q2 2019.
  • Median Debt to Equity over the past 5 years was $0.05 (2022), compared with a mean of -$1.78.
  • Biggest five-year swings in Debt to Equity: tumbled 38907.82% in 2019 and later soared 86179.66% in 2021.
  • Healthy Extracts' Debt to Equity stood at -$0.08 in 2018, then plummeted by 1453.54% to -$1.21 in 2019, then soared by 104.93% to $0.06 in 2020, then grew by 15.51% to $0.07 in 2021, then fell by 25.21% to $0.05 in 2022.
  • The last three reported values for Debt to Equity were $0.05 (Q3 2022), $0.01 (Q2 2022), and $0.21 (Q1 2022) per Business Quant data.